Ergomed plc, established in 1997 and based in Guildford, UK, delivers extensive clinical trial planning, management, and oversight services, alongside critical drug safety and medical information support. Through its subsidiaries, the company maintains a global presence, operating across the United Kingdom, the broader European continent, the Middle East, Africa, North America, Asia, and Australia. Its operations are divided into two core divisions: Clinical Research Services and Pharmacovigilance. Ergomed partners with pharmaceutical, biotechnology, and generic drug companies, offering expertise in clinical development, post-market management, and pharmacovigilance. The firm specializes in diverse therapeutic fields such as oncology, haematology, allergy, respiratory, and neurology/CNS disorders, with a particular emphasis on orphan drug development. Additionally, Ergomed provides crucial site support services for clinical studies. The company, initially known as Ergomed Clinical Research Limited, officially became Ergomed plc in June 2014.